Drugs / FB-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05650112 | Nov 2022 → Aug 2024 | — | Federation Bio Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FB-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05650112 ↗ |
| Route | Oral | “FB-001 is formulated as a powder in capsule intended for oral administration” NCT05650112 ↗ |